PDZD7-MYO7A complex identified in enriched stereocilia membranes

  1. Clive P Morgan
  2. Jocelyn F Krey
  3. M'Hamed Grati
  4. Bo Zhao
  5. Shannon Fallen
  6. Abhiraami Kannan-Sundhari
  7. Xue Zhong Liu
  8. Dongseok Choi
  9. Ulrich Müller
  10. Peter G Barr-Gillespie  Is a corresponding author
  1. Oregon Health and Science University, United States
  2. University of Miami, United States
  3. The Scripps Research Institute, United States

Abstract

While more than 70 genes have been linked to deafness, most of which are expressed in mechanosensory hair cells of the inner ear, a challenge has been to link these genes into molecular pathways. One example is Myo7a (myosin VIIA), in which deafness mutations affect the development and function of the mechanically sensitive stereocilia of hair cells. We describe here a procedure for the isolation of low-abundance protein complexes from stereocilia membrane fractions. Using this procedure, combined with identification and quantitation of proteins with mass spectrometry, we demonstrate that MYO7A forms a complex with PDZD7, a paralog of USH1C and DFNB31. MYO7A and PDZD7 interact in tissue-culture cells, and co-localize to the ankle-link region of stereocilia in wild-type but not Myo7a mutant mice. Our data thus describe a new paradigm for the interrogation of low-abundance protein complexes in hair cell stereocilia and establish an unanticipated link between MYO7A and PDZD7.

Data availability

The following data sets were generated
    1. Barr-Gillespie
    2. PG
    (2016) D10 Stereocilia Membrane Enrichment
    Available at the PRIDE Archive (accession no. PXD004222).

Article and author information

Author details

  1. Clive P Morgan

    Oregon Hearing Research Center, Oregon Health and Science University, Portland, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Jocelyn F Krey

    Oregon Hearing Research Center, Oregon Health and Science University, Portland, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. M'Hamed Grati

    Department of Otolaryngology, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Bo Zhao

    Dorris Neuroscience Center, The Scripps Research Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Shannon Fallen

    Oregon Hearing Research Center, Oregon Health and Science University, Portland, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Abhiraami Kannan-Sundhari

    Department of Otolaryngology, Miller School of Medicine,, University of Miami, Miami, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Xue Zhong Liu

    Department of Otolaryngology, Miller School of Medicine,, University of Miami, Miami, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Dongseok Choi

    OHSU-PSU School of Public Health, Oregon Health and Science University, Portland, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Ulrich Müller

    Dorris Neuroscience Center, The Scripps Research Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Peter G Barr-Gillespie

    Oregon Hearing Research Center, Oregon Health and Science University, Portland, United States
    For correspondence
    gillespp@ohsu.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9787-5860

Funding

National Institute on Deafness and Other Communication Disorders (R01DC002368)

  • Peter G Barr-Gillespie

National Institute on Deafness and Other Communication Disorders (P30DC005983)

  • Peter G Barr-Gillespie

National Institute on Deafness and Other Communication Disorders (R01DC014427)

  • Ulrich Müller
  • Peter G Barr-Gillespie

National Institute on Deafness and Other Communication Disorders (R01DC005965)

  • Ulrich Müller

National Institute on Deafness and Other Communication Disorders (R01DC05575)

  • Xue Zhong Liu

National Institute on Deafness and Other Communication Disorders (R01DC012546)

  • Xue Zhong Liu

National Institute on Deafness and Other Communication Disorders (R01DC012115)

  • Xue Zhong Liu

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Jeremy Nathans, Johns Hopkins University School of Medicine, United States

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled and euthanized according to a protocol (#IS00003292) that was approved by the institutional animal care and use committee (IACUC) of the Oregon Health & Science University.

Version history

  1. Received: June 24, 2016
  2. Accepted: August 14, 2016
  3. Accepted Manuscript published: August 15, 2016 (version 1)
  4. Version of Record published: August 30, 2016 (version 2)

Copyright

© 2016, Morgan et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,049
    views
  • 495
    downloads
  • 39
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Clive P Morgan
  2. Jocelyn F Krey
  3. M'Hamed Grati
  4. Bo Zhao
  5. Shannon Fallen
  6. Abhiraami Kannan-Sundhari
  7. Xue Zhong Liu
  8. Dongseok Choi
  9. Ulrich Müller
  10. Peter G Barr-Gillespie
(2016)
PDZD7-MYO7A complex identified in enriched stereocilia membranes
eLife 5:e18312.
https://doi.org/10.7554/eLife.18312

Share this article

https://doi.org/10.7554/eLife.18312

Further reading

    1. Cancer Biology
    2. Cell Biology
    Camille Dantzer, Justine Vaché ... Violaine Moreau
    Research Article

    Immune checkpoint inhibitors have produced encouraging results in cancer patients. However, the majority of ß-catenin-mutated tumors have been described as lacking immune infiltrates and resistant to immunotherapy. The mechanisms by which oncogenic ß-catenin affects immune surveillance remain unclear. Herein, we highlighted the involvement of ß-catenin in the regulation of the exosomal pathway and, by extension, in immune/cancer cell communication in hepatocellular carcinoma (HCC). We showed that mutated ß-catenin represses expression of SDC4 and RAB27A, two main actors in exosome biogenesis, in both liver cancer cell lines and HCC patient samples. Using nanoparticle tracking analysis and live-cell imaging, we further demonstrated that activated ß-catenin represses exosome release. Then, we demonstrated in 3D spheroid models that activation of β-catenin promotes a decrease in immune cell infiltration through a defect in exosome secretion. Taken together, our results provide the first evidence that oncogenic ß-catenin plays a key role in exosome biogenesis. Our study gives new insight into the impact of ß-catenin mutations on tumor microenvironment remodeling, which could lead to the development of new strategies to enhance immunotherapeutic response.

    1. Cell Biology
    Zhongyun Xie, Yongping Chai ... Wei Li
    Research Article

    Asymmetric cell divisions (ACDs) generate two daughter cells with identical genetic information but distinct cell fates through epigenetic mechanisms. However, the process of partitioning different epigenetic information into daughter cells remains unclear. Here, we demonstrate that the nucleosome remodeling and deacetylase (NuRD) complex is asymmetrically segregated into the surviving daughter cell rather than the apoptotic one during ACDs in Caenorhabditis elegans. The absence of NuRD triggers apoptosis via the EGL-1-CED-9-CED-4-CED-3 pathway, while an ectopic gain of NuRD enables apoptotic daughter cells to survive. We identify the vacuolar H+–adenosine triphosphatase (V-ATPase) complex as a crucial regulator of NuRD’s asymmetric segregation. V-ATPase interacts with NuRD and is asymmetrically segregated into the surviving daughter cell. Inhibition of V-ATPase disrupts cytosolic pH asymmetry and NuRD asymmetry. We suggest that asymmetric segregation of V-ATPase may cause distinct acidification levels in the two daughter cells, enabling asymmetric epigenetic inheritance that specifies their respective life-versus-death fates.